We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Surgical Problems in Management of Islet-Cell Tumors with Gastric Hypersecretion

M. A. BLOCK, M.D.; R. F. SMITH, M.D.; W. S. HAUBRICH, M.D.; R. C. HORN, M.D.
Arch Surg. 1962;85(2):270-278. doi:10.1001/archsurg.1962.01310020100020.
Text Size: A A A
Published online


The recognition in recent years of the association of islet-cell tumors of the pancreas and gastric hypersecretion has been followed by reports of an increasing number of patients manifesting this condition by recurrent gastrointestinal ulcer disease or, in fewer patients, by an intractable diarrhea.1,2 These patients characteristically produce an overnight volume of gastric juice in excess of a liter, containing over 100 mEq. per liter of free hydrochloric acid. The ulcer disease is frequently fulminant with recurrent life-endangering duodenal, jejunal, or marginal ulceration, and the diarrhea can be sufficiently severe to produce death. Experience has shown that in at least 50% of patients the islet-cell tumors are malignant, about 20% are located in aberrant locations, about 10% consist of a diffuse adenomatosis, and approximately 20% are associated with polyglandular endocrine disease.3 Some, but not all, experimental evidence reported indicates that extracts of the tumors do stimulate gastric secretion.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.